Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Budesonide MMX add-on to oral 5-ASA for active mild to moderate ulcerative colitis
2011-005115-82Phase 3Completed
- Sponsor
- Santarus, Inc.
- Start
- Feb 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of budesonide MMX in autoimmune colitis, sponsored by Santarus, Inc.. Started Feb 2012; status: completed.
02
Drugs
budesonide MMX
03
Conditions
autoimmune colitis
Beyond the preview
Go deeper on 2011-005115-82.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-005115-82.